Mandy Cohen, MD, MPH, will take over the CDC; abortion activists acknowledge 1 year without Roe v Wade; Bristol Myers Squibb (BMS) challenges Medicare’s drug price negotiation program.
Biden Appoints Dr Mandy Cohen as New CDC Director
President Joe Biden has chosen Mandy Cohen, MD, MPH, former state health secretary in North Carolina, as the next director of the CDC, according to NPR. Cohen, who has been praised for her experience and leadership, will take over from Rochelle Walensky, MD, MPH, with the goal of rebuilding the agency's morale and reputation. Walensky steps down June 30. Supporters of Cohen view her as a seasoned leader in public health and politics, capable of implementing operational changes and navigating political challenges.
Marking the 1-Year Anniversary Since the Overturning of Roe v Wade
Abortion rights advocates and opponents are gearing up to mark the 1-year anniversary of the Supreme Court's decision to overturn the Roe v Wade ruling, according to Reuters. Both supporters and opponents of the decision are planning events to rally voters and draw attention to the ongoing battles over abortion access. Furthermore, abortion rights remain at the center of political debate, which experts expect will continue to be a big motivation factor for voters.
Bristol Myers Squibb Files Lawsuit Against Medicare’s Drug Price Negotiation Program
On Friday, Bristol Myers Squibb (BMS) joined other organizations in filing a legal challenge against the Medicare drug price negotiation program established by the Inflation Reduction Act, according to The Hill. BMS alleges that the provision, which allows Medicare to negotiate drug prices, violates the first and fifth amendments. The company argues that the program forces pharmaceutical companies to provide medicines at government-set prices without reflecting fair market value and compels them to make false statements about the nature of the price negotiation process.
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More